Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 工學院
  3. 工業工程學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/101677
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor黃道宏zh_TW
dc.contributor.advisorDow-Hon Huangen
dc.contributor.author鄭宇成zh_TW
dc.contributor.authorYu-Cheng Zhengen
dc.date.accessioned2026-02-26T16:38:06Z-
dc.date.available2026-02-27-
dc.date.copyright2026-02-26-
dc.date.issued2026-
dc.date.submitted2026-02-06-
dc.identifier.citation[1] F. J. Anscombe. On estimating binomial response relations. Biometrika,43(3/4):461–464, 1956.
[2] M. K. Arumugam, M. C. Paal, J. Donohue, Terrence M., M. Ganesan, N. A. Osna,and K. K. Kharbanda. Beneficial effects of betaine: A comprehensive review.Biology, 10(6):456, 2021.
[3] A. Association. Machine learning-based integration of modifiable risk factors for predicting cognitive decline and alzheimer’s disease progression. Alzheimer’s Dementia, 20(S12):e070182, 2024.
[4] P. C. Austin. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research, 46(3):399–424, 2011.
[5] R. L. Bailey, V. L. Fulgoni, C. L. Taylor, C. M. Pfeiffer, S. V. Thuppal, G. P. Mc-Cabe, and E. A. Yetley. Correspondence of folate dietary intake and biomarker data.American Journal of Clinical Nutrition, 105(6):1336–1343, 2017.
[6] N. R. Barthélemy, K. Horie, C. Sato, and R. J. Bateman. Blood plasma phosphorylated-tau isoforms track cns change in alzheimer’s disease. Journal of Experimental Medicine, 217(11):e20200861, Nov. 2020.
[7] D. N. Chester, J. D. Goldman, J. K. Ahuja, and A. J. Moshfegh. Dietary intakes of choline: What we eat in america, nhanes 2007–2008. Technical Report Dietary Data Brief No. 9, U.S. Department of Agriculture, Agricultural Research Service, Food Surveys Research Group, Beltsville, MD, 2011.doi:doi:10.6342/NTU202600571
[8] D.-M. Chu, M. L. Wahlqvist, H.-Y. Chang, N.-H. Yeh, and M.-S. Lee. Choline and betaine food sources and intakes in taiwanese. Asia Pacific Journal of Clinical Nutrition, 21(4):547–557, 2012.
[9] W. Chun and G. V. Johnson. The role of tau phosphorylation and cleavage in neuronal cell death. Frontiers in Bioscience, 12:733–756, Jan. 2007.
[10] R. M. Crum, J. C. Anthony, S. S. Bassett, and M. F. Folstein. Population-based norms for the mini-mental state examination by age and educational level. JAMA, 269(18):2386–2391, 1993.
[11] M. Ester, H.-P. Kriegel, J. Sander, X. Xu, et al. A density-based algorithm for discovering clusters in large spatial databases with noise. In kdd, volume 96, pages 226–231, 1996.
[12] M. F. Folstein, S. E. Folstein, and P. R. McHugh. ”mini-mental state”. a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3):189–198, Nov. 1975.
[13] S. Friso, S. Udali, D. De Santis, and S.-W. Choi. One-carbon metabolism and epigenetics. Molecular Aspects of Medicine, 54:28–36, 2017.
[14] M. Goedert, M. G. Spillantini, and R. A. Crowther. Tau proteins and neurofibrillary degeneration. Brain Pathology, 1(4):279–286, July 1991.
[15] P. J. Green and B. W. Silverman. Nonparametric Regression and Generalized Linear Models. Chapman and Hall, 1994.
[16] J. B. Haldane. The mean and variance of χ2, when used as a test of homogeneity, when expectations are small. Biometrika, 31(3/4):346–355, 1940.
[17] T. J. Hastie and R. J. Tibshirani. Generalized Additive Models.Chapman and Hall/CRC, 1990.
[18] D. W. Hosmer Jr, S. Lemeshow, and R. X. Sturdivant. Applied logistic regression, volume 398. John Wiley & Sons, 3 edition, 2013.
[19] K. Iqbal, A. A. C., S. Chen, M. O. Chohan, E. El-Akkad, C. X. Gong, S. Khatoon,B. Li, F. Liu, A. Rahman, H. Tanimukai, and I. Grundke-Iqbal. Tau pathology in alzheimer disease and other tauopathies. Biochimica et Biophysica Acta (BBA) -Molecular Basis of Disease, 1739(2-3):198–210, Jan.2005.
[20] L. Keele and R. Grieve. So many choices: A guide to selecting among methods for estimating causal effects. Statistics in Medicine, 44(5):e10336, 2025.
[21] N. Keiding and D. Clayton. Standardization and control for confounding in observational studies: A historical perspective. Statistical Science, 29(4):529–558, 2014.
[22] G. Kimeldorf and G. Wahba. Some results on tchebycheffian spline functions. Journal of Mathematical Analysis and Applications, 33(1):82–95, 1971.
[23] J. G. Li, J. Chu, C. Barrero, et al. Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of alzheimer disease withpl aques and tangles. Annals of Neurology, 75(6):851–863, 2014.
[24] G. Livingston, J. Huntley, A. Sommerlad, D. Ames, C. Ballard, S. Banerjee, C. Brayne, A. Burns, J. Cohen-Mansfield, C. Cooper, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. The Lancet, 404(10452):572–628, 2024.
[25] F. Ma, T. Wu, J. Zhao, L. Ji, A. Song, M. Zhang, G. Huang, T. Feng, J. Ni, and X. Zhang. Plasma homocysteine and serum folate and vitamin B12 levels in mild cognitive impairment and Alzheimer’s disease: A case-control study. Nutrients,9(7):725, 2017.
[26] H. B. Mann and D. R. Whitney. On a test of whether one of two random variables is stochastically larger than the other. The Annals of Mathematical Statistics, 18(1):50–60, 1947.
[27] A. Martorana, Z. Esposito, and G. Koch. Beyond the cholinergic hypothesis: do current drugs work in alzheimer’s disease? CNS Neuroscience & Therapeutics,16(4):235–245, Aug. 2010.
[28] P. D. Meek, K. McKeithan, and G. T. Schumock. Economic considerations in alzheimer’s disease. Pharmacotherapy, 18(2 Pt 2):68–73, Mar. 1998. discussion 79–82.
[29] N. Mendonça, J. C. Mathers, A. J. Adamson, C. Martin-Ruiz, C. J. Seal, C. Jagger, and T. R. Hill. Intakes of folate and vitamin b12 and biomarkers of status in the very old: The newcastle 85+ study. Nutrients, 8(10):604, 2016.
[30] J. E. J. Meredith, S. Sankaranarayanan, V. Guss, A. J. Lanzetti, F. Berisha, R. J. Neely, and et al. Characterization of novel csf tau and ptau biomarkers for alzheimer's disease. PLOS ONE, 8(10):e76523, 2013.
[31] J. C. Morris. The clinical dementia rating (cdr): Current version and scoring rules.Neurology, 43(11):2412–2414, 1993.
[32] D. Mungas. In-office mental status testing: a practical guide. Geriatrics, 46(7):54–58, 63, 66, July 1991.
[33] E. Nurk, H. Refsum, I. Bjelland, C. A. Drevon, G. S. Tell, P. M. Ueland, and S. E.Vollset. Plasma free choline, betaine and cognitive performance: The Hordaland health study. British Journal of Nutrition, 109(3):511–519, 2013.
[34] S. E. O’Bryant, S. C. Waring, C. M. Cullum, J. Hall, L. Lacritz, P. J. Massman, P. Lupo, J. S. Reisch, and R. Doody. Staging dementia using clinical dementia rating scale sum of boxes scores: A texas alzheimer’s research consortium study. Archives of Neurology, 65(8):1091–1095, 2008.
[35] Office of Dietary Supplements. Choline: Fact sheet for health professionals. National Institutes of Health, Office of Dietary Supplements, 2022. Updated June 2, 2022.
[36] C. Poly, J. M. Massaro, S. Seshadri, P. A. Wolf, E. Cho, E. Krall, P. F. Jacques, and R. Au. The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham offspring cohort. American Journal of Clinical Nutrition, 94(6):1584–1591, 2011.
[37] G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Porcellini, and F. Licastro. Homocysteine and folate as risk factors for dementia and alzheimer disease. American Journal of Clinical Nutrition, 82(3):636–643, 2005.
[38] N. Ross. Generalized additive models in R: A free interactive course. https://noamross.github.io/gams-in-r-course/, 2019. [Online; accessed 2025-11-18].
[39] S. Seshadri, A. Beiser, J. Selhub, P. F. Jacques, I. H. Rosenberg, R. B. D’Agostino, P. W. F. Wilson, and P. A. Wolf. Plasma homocysteine as a risk factor for dementia and alzheimer’s disease. New England Journal of Medicine, 346(7):476–483, 2002.
[40] Y. Shang, L. Widman, and H. Hagström. Nonalcoholic fatty liver disease and risk of dementia: A population-based cohort study. Neurology, 99(6):e574–e582, Aug.2022.
[41] L. Shen and H.-F. Ji. Associations between homocysteine, folic acid, vitamin b12 and alzheimer’s disease: Insights from meta-analyses. Journal of Alzheimer’s Disease, 46(3):777–790, 2015.
[42] R. Shi, Z. Liu, and C. Xiong. A comprehensive review and tutorial on confounding adjustment methods for estimating treatment effects using observational data. Applied Sciences, 14(9):3662, 2024.
[43] F. Sun et al. Cognitive function and dietary index for gut microbiota in the aging population: Association and machine learning screening models. Published in Elsevier Inc. / PubMed, Online ahead of print, 2025. PMID: 40972802.
[44] G. D. Tomova, K. F. Arnold, M. S. Gilthorpe, and P. W. G. Tennant. Adjustment for energy intake in nutritional research: a causal inference perspective. American Journal of Clinical Nutrition, 115(1):189–198, 2022.
[45] A. van Hummel, G. Taleski, J.-M. Sontag, et al. Methyl donor supplementation reduces phospho-tau, fyn and demethylated protein phosphatase 2a levels and mitigates learning and motor deficits in a mouse model of tauopathy. Neuropathology and Applied Neurobiology, 49(4):e12931, 2023.
[46] A. van Hummel, G. Taleski, J.-M. Sontag, A. F. Feiten, Y. D. Ke, L. M. Ittner, and E. Sontag. Methyl donor supplementation reduces phospho-tau, fyn and demethylated protein phosphatase 2a levels and mitigates learning and motor deficits in a mouse model of tauopathy. Neuropathology and Applied Neurobiology,49(4):e12931, Aug. 2023.
[47] A. G. Vrahatis, E. Kaila, T. P. Exarchos, and P. Vlamos. Predicting the rapid progression of mild cognitive impairment to alzheimer's disease using machine learning: A systematic review. Neurodegenerative Diseases, 23(3-4):43–62, 2023.
[48] G. Wahba. Spline Models for Observational Data. SIAM, 1990.
[49] Q. Wang, G. Chen, J. Zhang, W. Zhang, and Z. Zhang. Homocysteine and folic acid:Risk factors for Alzheimer’s disease? Frontiers in Aging Neuroscience, 13:665114,2021.
[50] B. L. Welch. The generalization of ‘student’s’ problem when several different population variances are involved. Biometrika, 34(1/2):28–35, 1947.
[51] Wikipedia contributors. DBSCAN — Wikipedia, the free encyclopedia. https://zh.wikipedia.org/zh-tw/DBSCAN, 2025. [Online; accessed 2025-11-18].
[52] W. C. Willett, G. R. Howe, and L. H. Kushi. Adjustment for total energy intake in epidemiologic studies. American Journal of Clinical Nutrition, 65(4 Suppl):1220S–1228S, 1997.
[53] W. C. Willett, M. Stampfer, and D. K. Tobias. Re: Adjustment for energy intake in nutritional research: a causal inference perspective. American Journal of Clinical Nutrition, 116(2):608–609, 2022.
[54] World Health Organization. Dementia - fact sheet. https://www.who.int/news-room/fact-sheets/detail/dementia, 2024. Accessed: 2025-07-21.
[55] M. P. T. Ylilauri, S. Voutilainen, E. Lönnroos, H. E. K. Virtanen, T.-P. Tuomainen, J. T. Salonen, and J. K. Virtanen. Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease risk factor study. American Journal of Clinical Nutrition, 110(6):1416–1423,2019.
[56] L. Yuan, Y. Zhang, Y. Wu, A. Zhang, H. Bai, M. He, Z. Wang, and L. Zheng. Machine learning-based early screening of mild cognitive impairment using nutrition-related biomarkers and functional indicators. Frontiers in Aging Neuroscience, 17:1641690,2025.
[57] S. H. Zeisel. Choline: an essential nutrient for humans. Nutrition, 16(7):669–671,2000.
[58] S. H. Zeisel, M.-H. Mar, J. C. Howe, and J. M. Holden. Concentrations of cholinecontaining compounds and betaine in common foods. The Journal of Nutrition, 133(5):1302–1307, May 2003. Erratum in: J Nutr. 2003 Sep;133(9):2918.
[59] C.-E. Zhang, Q. Tian, W. Wei, et al. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2a in rat hippocampus. Neurobiology of Aging,29(11):1654–1665, 2008.
[60] J. Zuk, I. Krela-Kaźmierczak, M. Kaczmarek-Ryś, and A. Śliwińska. Dietary choline intake in european and non-european populations: current status and future trends —a narrative review. Nutrition Journal, 23(1):68, 2024.
-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/101677-
dc.description.abstract隨著人類壽命的延長,阿茲海默症已成為重要的文明病之一。若能透過日常營養攝取來預防阿茲海默症,不僅有助於降低醫療成本,亦具備操作簡單、容易落實的優點。本研究旨在運用機器學習技術,探討葉酸(Folate)、膽鹼(Choline)與甜菜鹼(Betaine)之攝取量與認知功能及失智風險的關聯性。方法上,本研究捨棄傳統的硬性填補(Hard Imputation),轉而利用 廣義相加模型(Generalized Additive Models, GAM)之平滑函數(Smoothing Functions) 捕捉營養素與認知功能間的非線性反應曲線。針對多維數據之缺失與交互作用,進一步導入張量積平滑 (Tensor Product Smooths, $te$),藉由其優異的插值特性與對數據稀疏性(Sparsity)的適應力,在不損失樣本統計代表性的前提下,藉由平滑函數擬合數據之全局趨勢,有效緩解高比例缺失數據對分析結果的偏誤,精確刻畫葉酸、膽鹼與甜菜鹼間的協同效應,並結合空間密度分群演算法 (Density-Based Spatial Clustering of Applications with Noise, DBSCAN),於 GAM 重建之連續曲面中識別出高認知保護力的營養攝取叢集(Clusters),最終針對不同性別與年齡族群,提出精準的營養攝取建議,以期達成預防神經退化並維護高齡大腦功能的目標。
傳統營養科學在探討營養素對阿茲海默症之影響時,多半採用單一營養素的統計檢定,較少同時綜合多種營養素,因而可能忽略特徵之間的交互作用與潛在的非線性關係,使分析結果較為片面。本研究以 GAM 模型處理營養素與阿茲海默症之間可能存在的非線性關係,並且能以視覺化方式呈現各營養素的邊際與交互效果,彌補了傳統營養科學上的不足。
實驗結果顯示,由本研究方法篩選出的建議攝取範圍內樣本,其認知表現普遍優於其他攝取範圍之樣本。並且本研究之三合一營養素組合的認知功能表現也勝過傳統單一營養素的營養素表現。總體而言,本研究提供了一套兼具可解釋性與實務操作性的範圍篩選模組,對營養素攝取建議與失智預防策略具有高度應用價值。
zh_TW
dc.description.abstractAs human life expectancy increases, Alzheimer’s disease (AD) has emerged as a significant disease of civilization. Utilizing daily nutritional intake to prevent AD not only helps reduce healthcare costs but also offers the advantages of being easy to implement and maintain. This study aims to apply machine learning techniques to investigate the association between the intake of folate, choline, and betaine and their impact on cognitive function and dementia risk. Methodologically, this research eschews traditional hard imputation methods, which often introduce bias. Instead, it leverages the smoothing functions of Generalized Additive Models (GAM) to capture the non-linear response curves between nutrient intake and cognitive performance. To address missing data and complex interactions in multidimensional datasets, we further incorporate tensor product smooths ($te$). By utilizing its superior interpolation properties and adaptability to data sparsity, we fit the global trends of the data without compromising statistical representativeness, thereby mitigating the bias caused by high missing data rates. This approach allows for a precise characterization of the synergistic effects among folate, choline, and betaine. Subsequently, Density-Based Spatial Clustering of Applications with Noise (DBSCAN) is applied to the continuous surfaces reconstructed by the GAM to identify nutritional intake clusters associated with high cognitive protection. Ultimately, this study provides tailored nutritional intake recommendations for different genders and age groups, aiming to prevent neurodegeneration and maintain cognitive health in the elderly population.
Traditional nutritional epidemiology typically examines the effect of a single nutrient on Alzheimer's disease using classical statistical tests, and rarely analyzes multiple nutrients jointly. As a result, potential interactions between nutrients and nonlinear relationships may be overlooked, filling a significant gap in conventional nutritional research. In contrast, the GAM framework used in this study can flexibly capture possible nonlinear relationships between nutrient intake and Alzheimer's disease, while its interpretability and visualizability allow the marginal and interaction effects of each nutrient to be presented in an intuitive way, facilitating understanding and support from the medical and nutritional sciences.
The experimental results indicate that subjects within the recommended intake ranges identified by this methodology generally exhibited superior cognitive performance compared to those outside these ranges. Furthermore, the triple-nutrient combination proposed in this study demonstrated superior cognitive outcomes compared to traditional single-nutrient approaches. Overall, this study presents a range selection framework that is both interpretable and practically viable, offering high application value for formulating nutrient intake recommendations and dementia prevention strategies
en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2026-02-26T16:38:06Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2026-02-26T16:38:06Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents致謝i
摘要iii
Abstract v
目次vii
圖次xi
表次xiii
符號列表xv
第一章緒論1
1.1 研究背景. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 研究動機與目的. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.3 研究架構. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.4 研究貢獻. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
第二章文獻探討7
2.1 機器學習預測阿茲海默症相關研究. . . . . . . . . . . . . . . . . . 7
2.2 阿茲海默症病理機制與相關指標. . . . . . . . . . . . . . . . . . . . 10
2.2.1 認知功能評估:簡易心智狀態檢查表(MMSE) . . . . . . . . . . 10
2.2.2 核心病理指標:磷酸化Tau 蛋白(pTau) . . . . . . . . . . . . . . 11
2.2.3 代謝調節因子:同半胱胺酸(Homocysteine) 與單碳代謝. . . . . 11
2.3 機器學習. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.3.1 廣義相加模型( Generalized Additive Models, GAM) . . . . . . . 13
2.3.1.1 GAM 模型評估指標與統計檢定. . . . . . . . . . . . 16
2.3.2 空間密度分群演算法(Density-Based Spatial Clustering of Applications with Noise, DBSCAN) . . . . . . . . . . . . . . . . . . . . 17
2.3.2.1 空間密度分群演算法參數選擇方法. . . . . . . . . . 19
2.3.3 統計檢定與驗證方法. . . . . . . . . . . . . . . . . . . . . . . . 20
2.3.3.1 勝算比分析(Odds Ratio, OR) . . . . . . . . . . . . . 20
第三章研究方法23
3.1 研究資料來源. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.2 預測模型訓練. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3.2.1 混雜因子之處理(Confounding Adjustment) . . . . . . . . . . . 26
3.2.2 廣義相加模型之模型訓練. . . . . . . . . . . . . . . . . . . . . . 28
3.2.3 空間密度分群演算法之營養素區間識別. . . . . . . . . . . . . . 29
3.2.4 對最佳營養範圍梯度分析. . . . . . . . . . . . . . . . . . . . . . 34
3.3 研究方法總結:GAM-DBSCAN 最佳化流程. . . . . . . . . . . . . 35
第四章研究結果驗證37
4.1 國健署資料驗證. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
4.1.1 分組t 檢定. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
4.1.2 Odds Ratio 驗證. . . . . . . . . . . . . . . . . . . . . . . . . . . 41
4.2 臨床實驗資料驗證. . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
4.2.1 血液生化指標. . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.2.2 Adjusted Odds Ratio 驗證. . . . . . . . . . . . . . . . . . . . . . 47
4.3 其他發現. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.3.1 資料侷限性: 不做年齡分層. . . . . . . . . . . . . . . . . . . . . 53
4.3.1.1 不含年齡分層之DBSCAN 最佳攝取範圍. . . . . . 53
4.3.1.2 不做年齡分層-內部驗證. . . . . . . . . . . . . . . . 54
4.3.1.3 不做年齡分層-外部驗證. . . . . . . . . . . . . . . . 55
4.3.2 考慮更多變量:將教育程度納入GAM 模型. . . . . . . . . . . 61
4.3.2.1 基於含教育程度模型之DBSCAN 最佳攝取範圍. . 62
4.3.2.2 含教育程度-內部驗證. . . . . . . . . . . . . . . . . 62
4.3.2.3 含教育程度-外部驗證. . . . . . . . . . . . . . . . . 64
4.4 研究結果驗證總結. . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
第五章結論69
5.1 研究結論. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
5.1.1 GAM 與DBSCAN 範圍篩選模組之方法學貢獻. . . . . . . . . . 69
5.1.2 性別與年齡分層下的最佳攝取範圍與MMSE 關聯. . . . . . . . 70
5.1.2.1 內部與外部驗證:分群t 檢定一致性與差異. . . . . 71
5.1.2.2 粗OR 與調整後OR 的一致與差異. . . . . . . . . . 72
5.2 未來方向. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
5.2.1 資料與設計層面的延伸. . . . . . . . . . . . . . . . . . . . . . . 73
5.2.2 方法學與模型的深化. . . . . . . . . . . . . . . . . . . . . . . . 73
5.2.3 營養素與個體差異的整合. . . . . . . . . . . . . . . . . . . . . . 74
5.2.4 臨床與公共衛生應用. . . . . . . . . . . . . . . . . . . . . . . . 74
參考文獻77
附錄A — 名詞解釋85
-
dc.language.isozh_TW-
dc.subject廣義相加模型-
dc.subject阿茲海默症-
dc.subject空間密度分群演算法-
dc.subjectGeneralized Additive Model-
dc.subjectAlzheimer's disease-
dc.subjectDensity-Based Spatial Clustering of Applications with Noise-
dc.title以機器學習分析營養素對阿茲海默症影響之研究zh_TW
dc.titleA Study on Analyzing the Effects of Nutrients on Alzheimer’s Disease with Machine Learningen
dc.typeThesis-
dc.date.schoolyear114-1-
dc.description.degree碩士-
dc.contributor.coadvisor許瑞芬zh_TW
dc.contributor.coadvisorRwei-Fen Syuen
dc.contributor.oralexamcommittee藍俊宏;陳雨欣zh_TW
dc.contributor.oralexamcommitteeJakey BLUE;Yu-Hsin Chenen
dc.subject.keyword廣義相加模型,阿茲海默症空間密度分群演算法zh_TW
dc.subject.keywordGeneralized Additive Model,Alzheimer's diseaseDensity-Based Spatial Clustering of Applications with Noiseen
dc.relation.page87-
dc.identifier.doi10.6342/NTU202600571-
dc.rights.note同意授權(全球公開)-
dc.date.accepted2026-02-09-
dc.contributor.author-college工學院-
dc.contributor.author-dept工業工程學研究所-
dc.date.embargo-lift2031-02-02-
顯示於系所單位:工業工程學研究所

文件中的檔案:
檔案 大小格式 
ntu-114-1.pdf
  此日期後於網路公開 2031-02-02
1.89 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved